News 20 February 2026 Review led by researchers highlights potential treatment for alcohol use disorder

University Hospitals Birmingham colleagues are among the authors of an international research paper recently published in The Lancet. Led by Dr Pouya Ebrahimi, Specialty Registrar in Cardiology, and Dr Yash Kachela, Medical Student Undergraduate, the study…

News 20 February 2026 Birmingham researchers lead state-of-the-art review on heart disease in chronic kidney disease

Researchers from University Hospitals Birmingham and the University of Birmingham have carried out a commissioned state-of-the-art review on heart disease in chronic kidney disease (CKD). Published in leading cardiovascular journal Nature Reviews Cardiology, the review brings together decades of clinical, imaging and experimental evidence to provide an authoritative…

News 20 February 2026 New study aims to improve recovery after cancer treatment in older people

Researchers at University Hospitals Birmingham (UHB) and the University of Birmingham, in collaboration with Kings College London (KCL), are leading a new study to understand the factors that influence how well older people recover from cancer treatment and to find ways to keep the body strong. While age is a known…

News 12 December 2025 NIHR Birmingham Biomedical Research Centre appoints first-ever Deputy Directors

Professor Patricia Lalor and Professor Alex Richter, from the University of Birmingham, have been appointed as Deputy Directors of the National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre (BRC). This double appointment…

Events Who’s really in charge? The gut microbiome’s secret role in autoimmunity

Autoimmune diseases are on the rise – and many scientists now believe this is linked to changes in the gut microbiome. Join this online talk delivered by Prof Palak Trivedi (Consultant Gastroenterologist at UHB and researcher…

News 18 November 2025 Birmingham researchers lead world-first trial for rare liver disease treatment

University Hospitals Birmingham NHS Foundation Trust (UHB) has treated the first patient in an early-phase clinical trial investigating whether a new medical device, Carbalive, can slow disease progression of a rare liver disease called primary sclerosing…

Back to top

News 13 November 2025 Birmingham to lead the way in testing promising new cystinosis treatment

Queen Elizabeth Hospital Birmingham (QEHB) will lead a new clinical trial, backed by nearly £4 million in funding, to test a drug discovered by an “inspirational” University of Sunderland scientist dedicated to improving the treatment of…

Back to top

News 11 November 2025 Midlands Amyloidosis Service brings specialist care closer to home

Since opening in 2019, the Midlands Amyloidosis Service (MAS) at Queen Elizabeth Hospital Birmingham (QEHB) has been transforming care for people with amyloidosis, a rare and often challenging to diagnose condition. For patients who previously had…

Back to top

News 11 November 2025 Latest findings offer hope for patients with rare skin cancer

Researchers at Queen Elizabeth Hospital Birmingham (QEHB), a leading centre for the PROCLIPI Study, have contributed to new findings showing that patients with Cutaneous (skin) T-cell Lymphoma (CTCL) experienced improved overall survival when treated with mogamulizumab,…

Back to top